Amiko M. Uchida
( out of 25 reviews )

Amiko M. Uchida, MD

Languages spoken: English

Clinical Locations

Gastroenterology /GI Clinic UUH

Gastroenterology, Area E
Salt Lake City
801-213-9797

  • CLINICAL:

    Amiko Uchida, MD is a gastroenterologist at the University of Utah School of Medicine and specializes in caring for and conducting research focused on patients with immune disorders of the GI tract, such as eosinophilic GI disease (EGID) and inflammatory bowel diseases (IBD). Dr. Uchida is a Utah-native and obtained her medical degree from the University of Utah before going on to train in internal medicine at the University of Washington and gastroenterology at Massachusetts General Hospital, where she also completed EGID and IBD training.

    She has particular interest and expertise in the increasingly common, yet poorly understood disease called eosinophilic esophagitis (EoE) as well as other eosinophilic gastrointestinal diseases. She is the Co-Director of the University of Utah Multidisciplinary Eosinophilic Gastrointestinal Disease Clinic, which is one of approximately five clinics of its type in the United States.

    Dr. Uchida’s other academic interests include the advancement of women in medicine and science and physician well-being and heads the Women in Gastroenterology Council. In her free time, she loves spending time in the great outdoors with her family. They particularly enjoy hiking, biking, and skiing.

    RESEARCH:

    Amiko Uchida, MD is a basic and translational physician-scientist gastroenterologist at the University of Utah School of Medicine where she also obtained her medical degree. She trained in gastroenterology at Massachusetts General Hospital and completed her post-doctoral work in the laboratories of John Garber MD and Stephanie and Michael Dougan, PhD and MD PhD, respectively. Dr. Uchida’s clinical and research interests include immune disorders of the GI tract, such as eosinophilic GI diseases and inflammatory bowel diseases. In addition to being co-Clinical Director of the Eosinophilic GI Disease Clinic, she is the Director of the Gastrointestinal Biobank, which connects basic scientists with clinicians and patient biospecimens to better understand health and disease.

    She currently working with co-mentor June Round PhD and Kathryn Peterson, MD MSCI investigating the increasingly common, yet poorly understood disease called eosinophilic esophagitis (EoE) and other EGIDs. She focuses on signaling mechanisms of disease pathology, the microbiota, and therapeutic options for patients suffering from EoE. More specifically, her research program encompasses better defining how diet and the microbiome affect inflammation in EoE and what non-invasive markers or testing can be performed to manage the disease.

    Please navigate to the Clinical Trials tab for some of the research opportunities as a part of our growing program.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Gastroenterology)

    Patient Rating

    4.9 /5
    ( out of 25 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 18, 2024
    UH HOSPITALS AND CLINICS

    Dr. Uchida always is so good to take her time and answer every single question I have. Explains everything and can tell she truly wants the best for each of her patients & will look into any solution to get me the care I need. I have loved her as my doctor!

    September 20, 2024
    UH HOSPITALS AND CLINICS

    Dr. Uchida was warm and receptive. In spite of what was probably a very busy day of seeing patients, Dr. Uchida took time to listen and address my concerns. She wanted my feedback when it came to discuss treatment options, which give me more confidence in the care I'm receiving.

    June 07, 2024
    UH HOSPITALS AND CLINICS

    Dr Uchida very caring , Thorough and helpful

    June 07, 2024
    UH HOSPITALS AND CLINICS

    Dr Uchida is very caring and detail oriented doctor. She takes the time to ask questions and listens to what you have to say.

    April 26, 2024
    UH HOSPITALS AND CLINICS

    Doctor Uchida is the best. She is always a huge help. I would recommend her to anyone needing help with these things.

    March 01, 2024
    UH HOSPITALS AND CLINICS

    She was extremely thorough and helpednus solve a problem

    February 09, 2024
    UH HOSPITALS AND CLINICS

    Dr. Uchida was so helpful in answering all my questions and linking me with resources and care that I needed during this visit. The best gastroenterologist visit I've ever had!

    February 08, 2024
    UH HOSPITALS AND CLINICS

    Dr. Uchida is an expert in her profession. She is highly knowledgeable about my Chrons issue and takes the time to explain the most recent studies and medical care available to treat it. She also includes me in the decision making process which makes my care feel more like a productive relationship with my doctor than just a simple patient. I've had 5 GI doctors throughout my life and Dr Uchida is the best, hands down.

    August 07, 2023
    UH HOSPITALS AND CLINICS

    I am beyond pleased with the experience and care from Dr. Uchida. She was friendly, listened, and answered all my questions. For the first time in 20 years, I feel like I'm being taken care of.

    See More Patient Comments

  • CLINICAL:

    Amiko Uchida, MD is a gastroenterologist at the University of Utah School of Medicine and specializes in caring for and conducting research focused on patients with immune disorders of the GI tract, such as eosinophilic GI disease (EGID) and inflammatory bowel diseases (IBD). Dr. Uchida is a Utah-native and obtained her medical degree from the University of Utah before going on to train in internal medicine at the University of Washington and gastroenterology at Massachusetts General Hospital, where she also completed EGID and IBD training.

    She has particular interest and expertise in the increasingly common, yet poorly understood disease called eosinophilic esophagitis (EoE) as well as other eosinophilic gastrointestinal diseases. She is the Co-Director of the University of Utah Multidisciplinary Eosinophilic Gastrointestinal Disease Clinic, which is one of approximately five clinics of its type in the United States.

    Dr. Uchida’s other academic interests include the advancement of women in medicine and science and physician well-being and heads the Women in Gastroenterology Council. In her free time, she loves spending time in the great outdoors with her family. They particularly enjoy hiking, biking, and skiing.

    RESEARCH:

    Amiko Uchida, MD is a basic and translational physician-scientist gastroenterologist at the University of Utah School of Medicine where she also obtained her medical degree. She trained in gastroenterology at Massachusetts General Hospital and completed her post-doctoral work in the laboratories of John Garber MD and Stephanie and Michael Dougan, PhD and MD PhD, respectively. Dr. Uchida’s clinical and research interests include immune disorders of the GI tract, such as eosinophilic GI diseases and inflammatory bowel diseases. In addition to being co-Clinical Director of the Eosinophilic GI Disease Clinic, she is the Director of the Gastrointestinal Biobank, which connects basic scientists with clinicians and patient biospecimens to better understand health and disease.

    She currently working with co-mentor June Round PhD and Kathryn Peterson, MD MSCI investigating the increasingly common, yet poorly understood disease called eosinophilic esophagitis (EoE) and other EGIDs. She focuses on signaling mechanisms of disease pathology, the microbiota, and therapeutic options for patients suffering from EoE. More specifically, her research program encompasses better defining how diet and the microbiome affect inflammation in EoE and what non-invasive markers or testing can be performed to manage the disease.

    Please navigate to the Clinical Trials tab for some of the research opportunities as a part of our growing program.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Gastroenterology
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Gastroenterology)

    Education history

    Fellowship Eosinophilic Esophagitis and Inflammatory Bowel Disease - Massachusetts General Hospital Advanced Fellow
    Fellowship Gastroenterology - Massachusetts General Hospital Fellow
    Residency Internal Medicine - University of Washington Intern/Resident
    Professional Medical Medicine - University of Utah School of Medicine M.D.
    Undergraduate Major: Zoology; Minor: Chemistry - Weber State University B.S.

    Selected Publications

    Journal Article

    1. Pyne AL, Uchida AM, Hazel MW, Pletneva MA, Allen-Brady K, Peterson KA (2024). Differing Epithelial and Immunologic Activation Patterns Following Food Reintroduction Reveal Different Transcriptional Profiles in Active Eosinophilic Esophagitis. Gastroenterology. (Read full article)
    2. Benjamin L Wright, MD12, Juan Pablo Abonia, MD3, Edsel M Abud, MD, PhD45, Seema S Aceves, MD, PhD5, Steven J Ackerman, PhD6, Melinda Braskett, MD7, Joy W Chang, MD, MS8, Mirna Chehade, MD, MPH9, Gregory M Constantine, MD10, Carla M Davis, MD11, Evan S Dellon, MD, MPH12, Alfred D Doyle, PhD1, Raquel Durban, RD13, David A Hill MDPhD14, 15, Elizabeth T Jensen, MPH, PhD16, Anupama Kewalramani, MD17, Paneez Khoury, MD, MHSc10, Amy D Klion, MD10, Leah Kottyan, PhD3, Fei Li Kuang, MD, PhD18 Emily C McGowan, MD, PhD19, Melanie A Ruffner MD, PhD1415, Lisa A Spencer, PhD20, Jonathan M Spergel, MD, PhD1415, Amiko M Uchida, MD21, Joshua B Wechsler, MD, MSc22, Robert D Pesek, MD23 (2024). Advances and Ongoing Challenges in Eosinophilic Gastrointestinal Disorders presented at the CEGIR/TIGERS Symposium at the 2024 American Academy of Allergy, Asthma, & Immunology Meeting. . JACI.
    3. Pyne AL, Uchida AM, Hazel MW, Stubben CJ, Chang JW, Bailey DD, Gonsalves N, Allen-Brady K, Peterson KA, Pletneva MA (2024). Effect of benralizumab on histopathology and inflammatory signatures in a clinical cohort of eosinophilic esophagitis. Dis Esophagus. (Read full article)
    4. Forss A, Uchida AM, Roelstraete B, Ebrahimi F, Garber JJ, Sundstrm J, Ludvigsson JF (2024). Eosinophilic esophagitis and risk of incident major adverse cardiovascular events: a nationwide matched cohort study. Esophagus. (Read full article)
    5. Bozorg SR, Sderling J, Mrild K, Garber JJ, Uchida A, Neovius M, Ludvigsson JF, Everhov H (2024). Economic Burden of Eosinophilic Esophagitis: A Nationwide Cost-of-Illness Study. Am J Gastroenterol. (Read full article)
    6. Ding J, Garber JJ, Uchida A, Lefkovith A, Carter GT, Vimalathas P, Canha L, Dougan M, Staller K, Yarze J, Delorey TM, Rozenblatt-Rosen O, Ashenberg O, Graham DB, Deguine J, Regev A, Xavier RJ (2024). An esophagus cell atlas reveals dynamic rewiring during active eosinophilic esophagitis and remission. Nat Commun, 12(1), 3344.
    7. Ding J, Garber JJ, Uchida A, Lefkovith A, Carter GT, Vimalathas P, Canha L, Dougan M, Staller K, Yarze J, Delorey TM, Rozenblatt-Rosen O, Ashenberg O, Graham DB, Deguine J, Regev A, Xavier RJ (2024). An esophagus cell atlas reveals dynamic rewiring during active eosinophilic esophagitis and remission. Nat Commun, 15(1), 3344. (Read full article)
    8. Soni M, Peterson KA, Uchida AM (2024). Eosinophilic Gastrointestinal Diseases. JAMA.
    9. Uchida AM (2023). "Eosinophilic esophagitis is associated with increased risk of later inflammatory bowel disease in a nationwide Swedish population cohort. United European Gastroenterology Journal, 12(1), 34-43.
    10. Reddy CA, Allen-Brady K, Uchida AM, Peterson KA, Hoffman AM, Souza RF, Spechler SJ (2023). Achalasia is Strongly Associated with Eosinophilic Esophagitis and Other Allergic Disorders. Clin Gastroenterol Hepatol, 22(1), 34-41.e2. (Read full article)
    11. Warner ASC, Ufere NN, Patel NJ, Lau ES, Uchida AM, Hills-Dunlap K, Bromberg GK, Cunningham EA, Tagerman MD, Mills GG, Palamara K, Rigotti NA, Burnett-Bowie SM, Yeh DD, Tanguturi VK (2022). A Women in Medicine Trainees' Council: a model for women trainee professional development. Postgrad Med J, 99(1168), 79-82. (Read full article)
    12. Lopes EW, Boneschansker L, Chu JN, Ha JB, Badran YR, McLean Diaz P, Przybyszewski EM, Scheid JF, Subramanian S, Vlez C, Wilechansky RM, Changela M, Richter JM, Uchida AM, Lochhead P (2023). Improving the Consent Process With an Informed Consent Video Prior to Outpatient Colonoscopy. Gastro Hep Adv, 2(8), 1082-1087. (Read full article)
    13. Uchida AM, Ro G, Garber JJ, Roelstraete B, Ludvigsson JF (2022). Prior hospital-based infection and risk of eosinophilic esophagitis in a Swedish nationwide case-control study. United European Gastroenterol J, 10(9), 999-1007. (Read full article)
    14. Uchida, AM, Ro, G, Garber, JJ, Roelstraete, B, Ludvigsson, JF (2022). Prior hopsital-based infection and risk of eosinophilic esophagitis in a Swedish nationwide case-control study. United European Gastroenterol J, 1-9.
    15. Allen-Brady K, Colletier KJ, Woller S, Eliason K, Uchida AM, Ro G, Newman M, Peterson KA (2022). Eosinophilic Gastritis and Enteritis Are Increased in Families with Eosinophilic Esophagitis. Am J Gastroenterol, 118(2), 263-268. (Read full article)
    16. Pyne AL, Hazel MW, Uchida AM, Qeadan F, Jordan KC, Holman A, Harward B, Gleich GJ, Peterson KA (2022). Oesophageal secretions reveal local food-specific antibody responses in eosinophilic oesophagitis. Aliment Pharmacol Ther, 56(9), 1328-1336. (Read full article)
    17. Uchida AM, Ro G, Qiang L, Peterson KA, Round J, Dougan M, Dougan SK (2022). Human differentiated eosinophils release IL-13 in response to IL-33 stimulation. Front Immunol, 13, 946643. (Read full article)
    18. Kummerlowe C, Mwakamui S, Hughes TK, Mulugeta N, Mudenda V, Besa E, Zyambo K, Shay JES, Fleming I, Vukovic M, Doran BA, Aicher TP, Wadsworth MH 2nd, Bramante JT, Uchida AM, Fardoos R, Asowata OE, Herbert N, Yilmaz H, Klverpris HN, Garber JJ, Ordovas-Montaes J, Gartner ZJ, Wallach T, Shalek AK, Kelly P (2022). Single-cell profiling of environmental enteropathy reveals signatures of epithelial remodeling and immune activation. Sci Transl Med, 14(660), eabi8633. (Read full article)
    19. Garber JJ, Roelstraete B, Lochhead PJ, Uchida AM, Michalsson K, Oln O, Ludvigsson JF (2022). Risk of fractures in individuals with eosinophilic esophagitis: nationwide population-based cohort study. Esophagus. (Read full article)
    20. Garber JJ, Lochhead PJ, Uchida AM, Roelstraete B, Bergman D, Clements MS, Ludvigsson JF (2022). Increasing incidence of eosinophilic esophagitis in Sweden: a nationwide population study. Esophagus. (Read full article)
    21. Lenehan PJ, Cirella A, Uchida AM, Crowley SJ, Sharova T, Boland G, Dougan M, Dougan SK, Heckler M (2021). Type 2 immunity is maintained during cancer-associated adipose tissue wasting. Immunother Adv, 1(1), ltab011. (Read full article)
    22. Przybyszewski EM, Deshpande V, Uchida AM (2020). An Unsuspected Cause of Rectal Bleeding. Gastroenterology, 160(4), e1-e2. (Read full article)
    23. Kumar NL, Kugener G, Vemula A, Wasan S, Uchida AM, Scheid FJ, Yarze J, Saltzman JR (2020). Multi-center prospective validation study of the SAFE-T colonoscopy evaluation tool: a web-based smartphone application for evaluation of gastroenterology fellow performance in colonoscopy. Gastroenterol Rep (Oxf).
    24. Uchida AM, Boden EK, James EA, Shows DM, Konecny AJ, Lord JD (2020). Escherichiacoli-Specific CD4+ T Cells Have Public T-Cell Receptors and Low Interleukin 10 Production in Crohn's Disease. Cell Mol Gastroenterol Hepatol, 10(3), 507-526. (Read full article)
    25. Chou DB, Sworder B, Bouladoux N, Roy CN, Uchida AM, Grigg M, Robey PG, Belkaid Y (2012). Stromal-derived IL-6 alters the balance of myeloerythroid progenitors during Toxoplasma gondii infection. J Leukoc Biol, 92(1), 123-31. (Read full article)
    26. Uchida AM, Meyers RA, Cooper BG, Goller F (2010). Fibre architecture and song activation rates of syringeal muscles are not lateralized in the European starling. J Exp Biol, 213(Pt 7), 1069-78. (Read full article)

    Review

    1. Uchida AM, Burk CM, Rothenberg ME, Furuta GT, Spergel JM (2023). Recent advances in the treatment of eosinophilic esophagitis. [Review]. J Allergy Clin Immunol Pract, 11(9), 2654-2663.
    2. Uchida AM, Ro G, Garber JJ, Peterson KA, Round JL (2022). Models and Tools for Investigating Eosinophilic Esophagitis at the Bench. [Review]. Front Immunol, 13, 943518. (Read full article)

    Editorial

    1. Uchida AM, Dougan M (2021). Editorial: Penetration of food protein through the oesophageal mucosa-is this where EoE starts? Aliment Pharmacol Ther, 53(3), 447-448. (Read full article)

    Letter

    1. Spechler SJ, Reddy CA, Allen-Brady K, Uchida AM, Peterson KA, Hoffman AM, Souza RF (2023). Reply. [Letter to the editor]. Clin Gastroenterol Hepatol. (Read full article)
    2. Uchida AM, Rabinowitz LG, Harris CE, Clark VR, Duma N, Willers H (2021). Baby Steps in the Right Direction: Toward a Parental Leave Policy for Gastroenterology Fellows. [Letter to the editor]. Am J Gastroenterol, 116(11), 2300. (Read full article)
    3. Uchida AM, Lenehan PJ, Vimalathas P, Miller KC, Valencia-Yang M, Qiang L, Canha LA, Ali LR, Dougan M, Garber JJ, Dougan SK (2021). Tissue eosinophils express the IL-33 receptor ST2 and type 2 cytokines in patients with eosinophilic esophagitis. [Letter to the editor]. Allergy, 77, 656-660. (Read full article)
    4. Harris CE, Clark VR, Duma N, Uchida AM, Kowalski A (2021). Re: "The Intersection of Disability and Pregnancy: Risks for Maternal Morbidity and Mortality" by Signore et al. [Letter to the editor]. J Womens Health (Larchmt), 30(9), 1362-1363. (Read full article)

    Abstract

    1. Uchida AM, Vimalalthas P, Valencia-Yang M, Miller K, Garber J (2020). The IL-33 receptor ST2 is highly induced on IL- 13-expressing tissue eosinophils in eosinophilic esophagitis [Abstract]. 145(2), 43.

  • Clinical Trials